Bayer downgraded to Neutral from Overweight at JPMorgan
Bayer downgraded to Neutral from Overweight at JPMorgan. JPMorgan analyst Richard downgraded Bayer to Neutral and lowered his price target for the shares to EUR 70 from EUR 100. The analyst believes 2019 will be another “messy year” for the company.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.